SCHEMBL23720120

SCHEMBL23720120

OCCCCc1cccc(OCCCc2ccccc2)c1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CYP4F2 P78329 1/20 0.59
▸ CYP4A11 Q02928 1/20 0.59
▸ LTA4H P09960 1/20 0.51
▸ EPHX2 P34913 1/20 0.51
▸ KCNH2 Q12809 1/20 0.51
▸ PPARG P37231 1/20 0.50
▸ PPARA Q07869 1/20 0.50
▸ MAOA P21397 3/20 0.49
▸ MAOB P27338 3/20 0.49
▸ FFAR1 O14842 3/20 0.49
▸ DRD2 P14416 1/20 0.49
▸ DRD4 P21917 1/20 0.49
▸ DRD3 P35462 1/20 0.49
▸ SIRT2 Q8IXJ6 1/20 0.48
▸ MGLL Q99685 1/20 0.48
▸ BCHE P06276 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.47
▸ RECQL P46063 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24041871 0.92 CYP4F2 (0.71) CYP4F2CYP4A11LTA4HEPHX2KCNH2
SCHEMBL30458991 0.92 CYP4F2 (0.71) CYP4F2CYP4A11LTA4HEPHX2KCNH2
SCHEMBL6001982 0.90 CYP4F2 (0.69) CYP4F2CYP4A11LTA4HEPHX2KCNH2
SCHEMBL8767703 0.89 CYP4F2 (0.61) CYP4F2CYP4A11LTA4HEPHX2KCNH2
SCHEMBL20945397 0.89 CYP4F2 (0.53) CYP4F2CYP4A11KCNH2PPARGPPARA
SCHEMBL5760533 0.87 CYP4F2 (0.79) CYP4F2CYP4A11LTA4HEPHX2MAOB
SCHEMBL611426 0.86 CYP4F2 (0.50) CYP4F2CYP4A11LTA4HKCNH2PPARG
SCHEMBL10235887 0.86 PPARA (0.56) CYP4F2CYP4A11KCNH2PPARGPPARA
SCHEMBL9819766 0.85 CYP4F2 (0.53) CYP4F2CYP4A11PPARGPPARAMAOA
SCHEMBL10235872 0.84 PPARA (0.58) CYP4F2CYP4A11PPARGPPARAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210238133-A1 CYCLOPROPANATION METHOD OKINAWA INSTITUTE OF SCIENCE AND TECHNOLOGY SCHOOL CORPORATION (JP) 2021-08-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210238133-A1 CYCLOPROPANATION METHOD ADH1A, ADH1C, ADH5 CYP4F2 179/4885CYP4A11 38/4885LTA4H 901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback